Targeted Drug Shrinks Tumors In Hard-To-Treat Cancer
William A. Haseltine
·
2026-06-02
·
via Forbes - Healthcare
A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferryi…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。